Malignant Catatonia Versus Neuroleptic Malignant Syndrome.

adverse event atypical antipsychotic clinical case report consultation liaison psychiatry dantrolene diferential diagnosis emergency psychiatry neuroleptic malignant syndrome (nms) schizophrenia and other psychotic disorders subtypes of catatonia

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jun 2021
Historique:
accepted: 21 06 2021
entrez: 26 7 2021
pubmed: 27 7 2021
medline: 27 7 2021
Statut: epublish

Résumé

The clinical presentations of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) are similar, posing a diagnostic challenge. Here, we present a 58-year-old Caucasian male who presented to the emergency department with an altered mental state, fever, tachycardia, and rigidity. Labs were remarkable for elevated creatine phosphokinase (CPK) and leukocytosis. The patient was on a regimen of clozapine and cariprazine to manage schizophrenia, lorazepam to treat catatonia, and mirtazapine to treat insomnia and appetite stimulation. The patient was initially diagnosed with NMS after common metabolic, infectious, and substance-induced etiologies were ruled out. Within 72 hours of receiving dantrolene and lorazepam, the patient's fever, tachycardia, and other laboratory abnormalities resolved. However, when the patient's rigidity, waxy flexibility, mutism, and stupor persisted, the diagnosis was reconsidered and changed to MC. Our case discusses the overlapping clinical presentations of NMS and MC, demonstrating a diagnostic challenge.

Identifiants

pubmed: 34306883
doi: 10.7759/cureus.15818
pmc: PMC8295452
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e15818

Informations de copyright

Copyright © 2021, Desai et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Can J Psychiatry. 2009 Jul;54(7):437-45
pubmed: 19660165
Am J Psychiatry. 1989 Mar;146(3):324-8
pubmed: 2645794
Pediatr Emerg Care. 2019 May;35(5):e98
pubmed: 30964850
Acta Psychiatr Scand. 1990 Jan;81(1):3-5
pubmed: 2184638
Psychopharmacol Bull. 2019 Feb 15;49(1):84-91
pubmed: 30858642
Innov Clin Neurosci. 2018 Aug 01;15(7-8):20-22
pubmed: 30254795
CNS Spectr. 2000 Jul;5(7):54-7
pubmed: 18197156
World J Biol Psychiatry. 2009;10(1):70-3
pubmed: 19673089
Neuropsychiatr Dis Treat. 2017 Jan 16;13:161-175
pubmed: 28144147
World J Psychiatry. 2016 Dec 22;6(4):391-398
pubmed: 28078203
J Clin Psychopharmacol. 1996 Aug;16(4):315-9
pubmed: 8835707

Auteurs

Saral Desai (S)

Psychiatry, Brookdale University Hospital Medical Center, Brooklyn, USA.

Tinu Hirachan (T)

Psychiatry, Brookdale University Hospital Medical Center, Brooklyn, USA.

Anca Toma (A)

Psychiatry, Brookdale University Hospital Medical Center, Brooklyn, USA.

Adela Gerolemou (A)

Psychiatry, Brookdale University Hospital Medical Center, Brooklyn, USA.

Classifications MeSH